Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center

Journal of Surgical Oncology

Volumn 101, Issue 6, 2010, Pages 457-464

  Yang, Xiao Jun ^a   Li, Yan ^a   Yonemura, Yutaka ^b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b NPO Organization to Support Peritoneal Dissemination Treatment   (Japan)

Author keywords

Cytoreductive surgery; Gastric cancer; Hyperthermic intraperitoneal chemotherapy; Peritoneal carcinomatosis

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CHINESE DRUG; CISPLATIN; MITOMYCIN C;

ABDOMINAL ABSCESS; ADULT; ADVANCED CANCER; AGED; ARTICLE; ASCITES; BILE LEAKAGE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DRUG EFFICACY; DRUG SAFETY; ESCHERICHIA COLI INFECTION; FEMALE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; INTERSTITIAL PNEUMONIA; MALE; MULTIPLE CYCLE TREATMENT; PARALYTIC ILEUS; PATIENT SAFETY; PERITONITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; RESPIRATORY DISTRESS SYNDROME; SQUAMOUS CELL CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOMA; STOMACH TUMOR; SURGICAL DRAINAGE; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TREATMENT FAILURE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASCITES; CARCINOMA; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; FEMALE; GASTRECTOMY; HUMANS; HYPERTHERMIA, INDUCED; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; QUALITY OF LIFE; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 77950855501     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21519     Document Type: Article

References (47)

1. Bertuccio P, Chatenoud L, Levi F, et al.: Recent patterns in gastric cancer: A global overview. Int J Cancer 2009;125:666-673.
2. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Zhang WD, Miao SJ: Analysis on epidemic characteristics of cancer death rate in China. Chinese J Health Educ 2009;25:246-248. (In Chinese with English abstract).
4. Chen C, Chen LQ, Chen LD, et al.: Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: Analysis of 100 cases. Hepato-Gastroenterology 2008;55:991-997. (Pubitemid 351975972)
5. Zhang YH, Li Y, Chen C, et al.: Carcinoembryonic antigen level is related to tumor invasion into the serosa of the stomach: Study on 166 cases and suggestion for new therapy. Hepato-Gastroenterology 2009;56:1750-1754.
6. Zhan YQ, Li W, Sun XW, et al.: Long-term results of surgical treatment of stomach cancer: Clinical experience of forty years from Sun Yat-sen University Cancer Center. Chin J Surg 2005;43:1109-1113. (In Chinese with English abstract).
7. Blair SL, Chu DZ, Schwarz RE: Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. Ann Surg Oncol 2001;8:632-637.
8. Fizazi K, Doubre H, Le Chevalier T, et al.: Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: Results of a phase II study. J Clin Oncol 2003;21: 349-354. (Pubitemid 46606165)
9. Gómez Portilla A, Cendoya I, López de Tejada I, et al.: Peritoneal carcinomatosis of colorectal origin. Current treatment. Review and update. Rev Esp Enferm Dig 2005;97:716-737.
10. Yonemura Y, Bando E, Kawamura T, et al.: Cytoreduction and intraperitoneal chemotherapy for carcinomatosis from gastric cancer. Cancer Treat Res 2007;134:357-373.
11. Sadeghi B, Arvieux C, Glehen O, et al.: Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358-363. (Pubitemid 30051820)
12. Chu DZ, Lang NP, Thompson C, et al.:Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989;63:364-367.
13. Yamada S, Takeda T, Matsumoto K: Prognostic analysis of malignant pleural and peritoneal effusions. Cancer 1983;51:136-140. (Pubitemid 13169588)
14. Roviello F, Marrelli D, Manzoni GD, et al.: Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 2003;90:1113-1119. (Pubitemid 37152170)
15. Sugarbaker PH, YuW, Yonemura Y: Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: The evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 2003;21:233-248.
16. Yan TD, Black D, MStat D, et al.: A systematic review and metaanalysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 2007;14:2702-2713. (Pubitemid 47460649)
17. Averbach AM, Jacquet P: Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer. Br J Surg 1996;83:726-733.
18. Adam RA, Adam YG: Malignant ascites: Past, present, and future. J Am Coll Surg 2004;198:999-1011.
19. Yang XJ, Li Y, al-shammaa Hassan AH, et al.: et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: Results of 21 cases. Ann Surg Oncol 2009;16:345-351.
20. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-2nd English Edition. Gastric Cancer 1998; 1:10-24.
21. Sugarbaker PH: Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999;43:15-25.
22. Yonemura Y, Bandou E, Kinoshita K, et al.: Effective therapy for peritoneal dissemination in gastric cancer. Surg Oncol Clin N Am 2003;12:634-648. (Pubitemid 36920090)
23. Yonemura Y, Kawamura T, Bandou E, et al.: Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005; 92:370-375. (Pubitemid 40445602)
24. Stewart JH IV, Shen P, Levine EA: Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: Current status and future directions. Ann Surg Oncol 2005;12:765-777. (Pubitemid 41355928)
25. Sugarbak PH: Cytoreduction surgery and perioperative intraperitoneal chemotherapy as a curative approach to Pseudomyxoma peritonei syndrome. Eur J Surg Oncol 2001;27:239-243. (Pubitemid 32621746)
26. Shen P, Levine EA, Hall J, et al.: Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin c after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 2003;138:26-33. (Pubitemid 36055643)
27. Sugarbaker PH, Yonemura Y: Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: Best palliation with a ray of hope for cure. Oncology 2000;58:96-107.
28. Moon YW, Jeung HC, Rha SY, et al.: Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: A 15-year follow-up study at a single Korean institute. Ann Surg Oncol 2007;14:2730-2737.
29. Sakuramoto S, Sasako M, Yamaguchi T, et al.: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007;357:1810-1820. (Pubitemid 350044801)
30. Marrelli D, Roviello F, de Manzoni G, et al.: Different patterns of recurrence in gastric cancer depending on Lauren's histological type: Longitudinal study. World J Surg 2002;26:1160-1165. (Pubitemid 36920276)
31. Wu CW, Lo SS, Shen KH, et al.: Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer. World J Surg 2003;27:153-158.
32. Maehara Y, Hasuda S, Koga T, et al.: Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg 2000;87:353-357. (Pubitemid 30156364)
33. Moriguchi S, Maehara Y, Korenaga D, et al.: Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol 1992;1:341-346.
34. Kooby DA, Suriawinata A, Klimstra DS, et al.: Biologic predictors of survival in node-negative gastric cancer. Ann Surg 2003;237:828-837. (Pubitemid 38174518)
35. Fujimoto S, Shrestha RD, Kokubun M, et al.: Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988; 208:36-41.
36. Yonemura Y, Fujimura T, Nishimura G, et al.: Effects of intraoperative chemohyerthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996;119:437-444. (Pubitemid 26115838)
37. Yonemura Y, de Aretxabala X, Fujiwara T, et al.: Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: Final results of a randomized controlled study. Hepato-Gastroenterolgy 2001;48:1776-1782. (Pubitemid 34003526)
38. Scaringi S, Kianmanesh R, Sabate JM, et al.: Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: A single western center experience. EJSO 2008;34:1246-1252.
39. Fujimoto S, Takahashi M, Mutou T, et al.: Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 1999;85:529-534. (Pubitemid 29075274)
40. Hall JJ, Loggie BW, Shen P, et al.: Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg 2004;8:454-463. (Pubitemid 38561210)
41. Fujimura T, Yonemura Y, Fushida S, et al.: Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65:65-71. (Pubitemid 20026812)
42. Hamazoe R, Maeta M, Kaibara N: Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer final results of a randomized controlled study. Cancer 1994;73: 2048-2052. (Pubitemid 24107956)
43. Glehen O, Schreiber V, Cotte E, et al.: Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 2004;139:20-26. (Pubitemid 38049613)
44. Kim JY, Bae HS: A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). Gastric Cancer 2001;4:27-33.
45. Stephens AD, Alderman R, Chang D, et al.: Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999;6:790-796. (Pubitemid 30013658)
46. Fujimoto S, Takahashi M, Koyabayashi K, et al.: Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis. Cancer 1992;70:2754-2760.
47. Bozzetti F, Baratti D, Kusamura S, et al.: Logoregional treatment of peritoneal carcinomatosis from gastric cancer. J Surg Oncol 2008;98:273-276.